Predicted Trait | |
Reported Trait | Lung cancer |
Mapped Trait(s) | lung carcinoma (EFO_0001071) |
Score Construction | |
PGS Name | Genome-wide-PRS |
Development Method | |
Name | LDpred2 |
Parameters | r2>0.5, p-value = 5E-8 |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 1,143,554 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000607 |
Citation (link to publication) | Boumtje V et al. EBioMedicine (2024) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 85,716 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST004748 Europe PMC: 28604730 |
85,716 individuals | European | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM021091 | PSS011520| European Ancestry| 24,012 individuals |
PGP000607 | Boumtje V et al. EBioMedicine (2024) |
Reported Trait: Incident lung cancer | OR: 1.33 | AUROC: 0.893 [0.887, 0.898] | R²: 0.49 | Sex, age,BMI, smocking status(ever or never smoker), and the first 10 ancestry-based PCA | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011520 | Lung cancer diagnosis was confirmed by pathological examination using resected specimens. | — | [ ,
45.72 % Male samples |
Mean = 59.65 years | European (French cancadian) |
— | CARTaGENE, LORD | CARTaGENE data application number 890519 |